ISIN | CH1266245997 |
---|---|
Valor Number | 126624599 |
Bloomberg Global ID | UBESZIX SW |
Fund Name | UBS (CH) Investment Fund - Equities Switzerland All Net Zero Ambition NSL I-X-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This sub-fund invests primarily in equity paper and rights issued by companies which have their registered office in Switzerland and which, as holding companies, invest mainly in companies which have their registered office in Switzerland or conduct the majority of their business in Switzerland, in units of other collective investments that invest their assets in the investments referred to above, and in derivatives and structured products on the above investments. |
Peculiarities |
Current Price * | 1,100.06 CHF | 30.06.2025 |
---|---|---|
Previous Price * | 1,104.88 CHF | 27.06.2025 |
52 Week High * | 1,158.61 CHF | 03.03.2025 |
52 Week Low * | 977.56 CHF | 09.04.2025 |
NAV * | 1,100.06 CHF | 30.06.2025 |
Issue Price * | 1,100.06 CHF | 30.06.2025 |
Redemption Price * | 1,100.06 CHF | 30.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 481,838,326 | |
Unit/Share Assets *** | 481,838,326 | |
Trading Information SIX |
YTD Performance | +6.33% |
31.12.2024 - 30.06.2025
31.12.2024 30.06.2025 |
---|---|---|
1 month | -1.94% |
30.05.2025 - 30.06.2025
30.05.2025 30.06.2025 |
3 months | -2.03% |
31.03.2025 - 30.06.2025
31.03.2025 30.06.2025 |
6 months | +6.33% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
1 year | +3.13% |
01.07.2024 - 30.06.2025
01.07.2024 30.06.2025 |
2 years | +14.19% |
06.07.2023 - 30.06.2025
06.07.2023 30.06.2025 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 13.81% | |
---|---|---|
Novartis AG Registered Shares | 11.72% | |
Roche Holding AG | 10.99% | |
Zurich Insurance Group AG | 6.02% | |
Compagnie Financiere Richemont SA Class A | 5.18% | |
ABB Ltd | 5.02% | |
UBS Group AG Registered Shares | 4.98% | |
Swiss Re AG | 3.58% | |
Alcon Inc | 3.10% | |
Lonza Group Ltd | 2.88% | |
Last data update | 31.05.2025 |
TER | 0.01% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.01% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |